Insights

Strategic Partnerships Bionovis has established strategic collaborations with global industry leaders like Samsung Bioepis and national institutions such as Bio-Manguinhos, opening opportunities for technology transfer, co-development, and joint ventures in biopharmaceutical production.

Market Growth Potential Operating within Brazil's emerging biopharmaceutical sector and focusing on high-complexity biofármacos positions Bionovis for expansion as demand for biosimilars, biobetters, and innovative biologics increases both locally and globally.

Advanced Manufacturing With state-of-the-art infrastructure and expertise in monoclonal antibodies and therapeutic proteins, Bionovis offers potential for partnerships in contract manufacturing services or licensing agreements to expand production capacity.

Research & Innovation Bionovis’s focus on developing a pipeline of biosimilars and advanced biopharmaceuticals suggests opportunities for collaboration on early-stage research, clinical development, and technology licensing to accelerate product commercialization.

Technology Utilization Leveraging their modern technological stack, including SAP and WordPress, Bionovis demonstrates operational efficiency and digital capability, indicating readiness for digital partnerships, data management, and compliance solutions to enhance productivity.

Similar companies to Bionovis

Bionovis Tech Stack

Bionovis uses 8 technology products and services including WordPress, SAP, oEmbed, and more. Explore Bionovis's tech stack below.

  • WordPress
    Content Management System
  • SAP
    Customer Relationship Management
  • oEmbed
    Dev Tools
  • Shopify
    E-commerce
  • Swiper
    Javascript Libraries
  • PHP
    Programming Languages
  • Yoast SEO
    Search Engines
  • Apache
    Web Servers

Bionovis's Email Address Formats

Bionovis uses at least 1 format(s):
Bionovis Email FormatsExamplePercentage
First.Last@bionovis.com.brJohn.Doe@bionovis.com.br
49%
First-Last@bionovis.com.brJohn-Doe@bionovis.com.br
1%
First.Middle@bionovis.com.brJohn.Michael@bionovis.com.br
1%
First.Last@bionovis.com.brJohn.Doe@bionovis.com.br
49%

Frequently Asked Questions

What is Bionovis's official website and social media links?

Minus sign iconPlus sign icon
Bionovis's official website is bionovis.com.br and has social profiles on LinkedIn.

What is Bionovis's SIC code NAICS code?

Minus sign iconPlus sign icon
Bionovis's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Bionovis have currently?

Minus sign iconPlus sign icon
As of December 2025, Bionovis has approximately 287 employees across 3 continents, including South AmericaEuropeOceania. Key team members include Ceo: O. F.Ceo: O. F.Chief Scientific Officer: V. R.. Explore Bionovis's employee directory with LeadIQ.

What industry does Bionovis belong to?

Minus sign iconPlus sign icon
Bionovis operates in the Biotechnology Research industry.

What technology does Bionovis use?

Minus sign iconPlus sign icon
Bionovis's tech stack includes WordPressSAPoEmbedShopifySwiperPHPYoast SEOApache.

What is Bionovis's email format?

Minus sign iconPlus sign icon
Bionovis's email format typically follows the pattern of First.Last@bionovis.com.br. Find more Bionovis email formats with LeadIQ.

When was Bionovis founded?

Minus sign iconPlus sign icon
Bionovis was founded in 2012.

Bionovis

Biotechnology ResearchSão Paulo, Brazil201-500 Employees

A Bionovis é uma empresa brasileira 100% dedicada à biotecnologia, com a missão de pesquisar, desenvolver, fabricar e comercializar biofármacos complexos e de alta qualidade para melhorar a vida dos pacientes.

Inserida em um ambiente biofarmacêutico global promissor, a Bionovis inova como pioneira na produção de medicamentos biológicos de alta complexidade no Brasil. Com uma equipa de renome, parcerias globais com líderes da indústria e colaborações com as principais instituições públicas nacionais, estamos a estabelecer a tecnologia completa para a produção de uma variedade de anticorpos monoclonais e proteínas terapêuticas. Recursos humanos altamente qualificados, uma infraestrutura de classe mundial e a implementação de know-how de ponta no desenvolvimento e fabricação de medicamentos biológicos complexos são os pilares para a construção de um pipeline composto por biossimilares, biobetters e biofármacos inovadores.

****

Bionovis is a 100% Brazilian pharmaceutical biotechnology company with a mission to research, develop, manufacture and market high-quality complex biopharmaceuticals to improve the lives of patients.

Set in a promising global biopharmaceutical environment, Bionovis innovates as a pioneer in the production of highly complex biological medicines in Brazil. With a reputable team, global partnerships with industry leaders and collaborations with leading national public institutions, we are establishing the complete technology for the production of a variety of monoclonal antibodies and therapeutic proteins. Highly qualified human resources, a world-class infrastructure and the implementation of state of the art know-how in the development and manufacturing of complex biological drugs are the pillars for the construction of a pipeline composed of biosimilars, biobetters and innovative biopharmaceuticals.

Section iconCompany Overview

SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2012
Employees
201-500

Section iconFunding & Financials

  • $1M$10M

    Bionovis's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    Bionovis's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.